NEWS

A yes answer would not be fair... a no answer would not be true... so what? Well, think about what's happening in your business... progress relates to the ability to diagnose and treat more and...

An update and indications on future directions are available in the very interesting paper* from Antea DeMarsilis just published in Metabolism  It presents each class of agents by:  ✔️mechanism of action✔️details of administration ✔️side effect profile✔️...

biotech, pharma, medtech and lifescience Companies rely on us to develop their international market presence and access new b2b markets in switzerland and in the european union.  From the market access strategy to the local operations, direct or through a network of...

Proteomics allows a better understanding of the physiopathology of alzheimersdisease This statement is suggested and supported by: an amazing and comprehensive paper(1) by Sruti Rayaprolu et al. from Emory University school of medicine in Atlanta explains how and why...

Even though nobody's publishing epidemiological and mortality data every day CKD, Marta Ruiz-Ortega et al from Universidad Autónoma de Madrid reminds us in an interesting paper that this condition is progressing as a consequence of (besides the aging of...

Today’s a great Day for us, a great Day for Life Science, a great Day for the thousands of people working for Moderna and a great Day for him, Stéphane Bancel. FDA has issued an emergency use authorization for Moderna’s COVID 19 vaccine, few days after the Pfizer...

Although it is well known that viruses mutate, the announcement of the rapid spread of new variants of the COVID-19 virus in the UK and in South Africa had the effect of a bomb to many of us, all around the world. This news shouldn’t have come as a surprise as it was...